Faes Farma, S.A.

BME:FAE Voorraadrapport

Marktkapitalisatie: €1.1b

Faes Farma Toekomstige groei

Future criteriumcontroles 0/6

De winst van Faes Farma zal naar verwachting dalen met 1.4% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 1.5% per jaar. De winst per aandeel zal naar verwachting dalen met 1.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.2% zijn.

Belangrijke informatie

-1.4%

Groei van de winst

-1.5%

Groei van de winst per aandeel

Pharmaceuticals winstgroei26.0%
Inkomstengroei1.5%
Toekomstig rendement op eigen vermogen11.2%
Dekking van analisten

Low

Laatst bijgewerkt21 Nov 2024

Recente toekomstige groei-updates

Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 01
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Jul 31
Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 01
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Dec 18
Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Dec 04
Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Nov 24
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

May 03
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Sep 21
Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Is Faes Farma (BME:FAE) A Risky Investment?

Aug 03
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Jun 17
Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Is Faes Farma (BME:FAE) Using Too Much Debt?

Mar 27
Is Faes Farma (BME:FAE) Using Too Much Debt?

Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Dec 13
Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Nov 29
Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Is Faes Farma (BME:FAE) A Risky Investment?

Sep 21
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Jul 31
Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Is Faes Farma (BME:FAE) Using Too Much Debt?

May 01
Is Faes Farma (BME:FAE) Using Too Much Debt?

Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Apr 07
Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Mar 22
Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Mar 06
Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

Feb 22
Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Jan 16
I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

Dec 08
Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

Winst- en omzetgroeiprognoses

BME:FAE - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20265099293N/A3
12/31/20254999482N/A3
12/31/20244849061N/A3
9/30/202450498N/AN/AN/A
6/30/20244949744106N/A
3/31/202448295N/AN/AN/A
12/31/202347392-1101N/A
9/30/202347290N/AN/AN/A
6/30/202346990-998N/A
3/31/202346791N/AN/AN/A
12/31/20224628926107N/A
9/30/202246086N/AN/AN/A
6/30/20224668850113N/A
3/31/202244988N/AN/AN/A
12/31/2021429822080N/A
9/30/202141681N/AN/AN/A
6/30/202139874856N/A
3/31/202139473N/AN/AN/A
12/31/2020411735378N/A
9/30/202040877N/AN/AN/A
6/30/2020407735778N/A
3/31/202040968N/AN/AN/A
12/31/2019383644668N/A
9/30/201937960N/AN/AN/A
6/30/2019363595174N/A
3/31/201935154N/AN/AN/A
12/31/2018340524059N/A
9/30/201833451N/AN/AN/A
6/30/201833049N/A58N/A
3/31/201830847N/AN/AN/A
12/31/201728241N/A42N/A
9/30/201726639N/AN/AN/A
6/30/201725039N/A43N/A
3/31/201724138N/AN/AN/A
12/31/201623737N/A50N/A
9/30/201622635N/AN/AN/A
6/30/201622234N/A40N/A
3/31/201622032N/AN/AN/A
12/31/201521430N/A41N/A
9/30/201520728N/AN/AN/A
6/30/201520327N/A42N/A
3/31/201519626N/AN/AN/A
12/31/201419825N/A32N/A
9/30/201419523N/AN/AN/A
6/30/201419424N/A20N/A
3/31/201419220N/AN/AN/A
12/31/201319323N/A32N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De winst van FAE zal naar verwachting de komende 3 jaar dalen ( -1.4% per jaar).

Winst versus markt: De winst van FAE zal naar verwachting de komende 3 jaar dalen ( -1.4% per jaar).

Hoge groeiwinsten: De winst van FAE zal naar verwachting de komende 3 jaar dalen.

Omzet versus markt: De omzet van FAE ( 1.5% per jaar) zal naar verwachting langzamer groeien dan de markt Spanish ( 4.9% per jaar).

Hoge groei-inkomsten: De omzet van FAE ( 1.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen FAE zal naar verwachting over 3 jaar laag zijn ( 11.2 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y